ADAndrea Dulcey

Andrea Dulcey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrea Dulcey has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Andrea Duppenthaler

    Division of Pediatric Infectious Disease, Department of Pediatrics, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch

    1 shared publication
  • Christoph Aebi

    Division of Paediatric Infectious Diseases, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

    1 shared publication
  • Emilija Zimnickaite

    Department of Pediatrics, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch

    1 shared publication
  • Fabienne Stoller

    Department of Cardiology, Center for Congenital Heart Disease, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch

    1 shared publication
  • Florian Arndt

    Department of Cardiology, Center for Congenital Heart Disease, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch

    1 shared publication
  • Nina Schöbi

    Inselspital, Bern University Hospital, University of Bern

    1 shared publication

Latest Publications

  • Open Access

    Management of Coxiella burnetii Endocarditis in a Child With Congenital Heart Disease

    by Emilija Zimnickaite, Andrea Dulcey, Christoph Aebi, Andrea Duppenthaler, Nina Schöbi, Fabienne Stoller, Florian Arndt, Philipp K. A. Agyeman

    A 6‐year‐old male patient with pulmonary atresia and recent valve replacement with a Melody valve presented with a 6‐week history of fever and cough. He was diagnosed with Coxiella burnetii endocarditis based on a C. burnetii Phase I IgG antibody titre of 1:65,536 and increased metabolic activity surrounding his prosthetic cardiac valve on positron emission tomography scan. Treatment was initiated with doxycycline and hydroxychloroquine. However, despite dose escalation, target plasma concentrations were not achieved. The patient experienced rapid clinical improvement, and serological markers declined gradually. Antimicrobial therapy was discontinued after 40 months, as predefined serological criteria were met, clinical course was favourable, and a follow‐up positron emission tomography scan demonstrated a significant reduction in metabolic activity around the prosthetic valve. Up to 23 months after cessation of therapy, the patient showed no evidence of active C. burnetii endocarditis during follow‐up. The Melody valve maintained its function, and valve replacement was not required. Clinicians should employ an individualised treatment approach to children with C. burnetii endocarditis.